Literature DB >> 15509828

Rituximab for rheumatoid arthritis.

Hiroshi Okamoto, Naoyuki Kamatani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15509828     DOI： 10.1056/NEJM200410283511820

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  2 in total

1.  High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Nazmim S Bhuiya; Corey S Cutler; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Clin Cancer Res       Date:  2007-10-15       Impact factor: 12.531

2.  Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches.

Authors:  Chen Li; Anthony Rossomando; Shiaw-Lin Wu; Barry L Karger
Journal:  MAbs       Date:  2013-04-25       Impact factor: 5.857
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.